In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns.

INTRODUCTION Electronic cigarette users ("vapers") inhale aerosols of water, nicotine, and propylene glycol (PG) or vegetable glycerin (VG). Aerosol particle sizes should affect deposition patterns in vapers and bystanders. METHODS Aerosols were generated by a smoking machine and an electronic cigarette filled with 16mg/ml nicotine in aqueous PG or VG solution. A scanning mobility particle sizer (SMPS) counted particles of 10-1,000 nm diameters. A single puff experiment counted particles immediately and after aging 10 and 40 s. A steady-state experiment counted particles emitted from a collection chamber, untreated and after desiccation or organic vapor removal. The International Commission on Radiological Protection (ICRP) human respiratory tract model was used to estimate deposition. Results were compared to similar data from reference cigarettes. RESULTS Puffs generated peak particle counts at (VG) 180 nm and (PG) 120 nm. Steady-state peaks occurred around 400 nm. Organic vapor removal eliminated small particles and reduced the size and number of large particles. Desiccation reduced the total volume of particles by 70% (VG, small PG) to 88% (large PG). The ICRP model predicted 7%-18% alveolar delivery; 9%-19% venous delivery, mostly in the head; and 73%-80% losses by exhalation. Reference cigarettes generated more particles initially, but were otherwise similar; however, in vivo smoke particle deposition is higher than the model predicts. CONCLUSIONS Nicotine delivery may depend on vaping technique, particle evolution, and cloud effects. Predicted 10% arterial and 15% venous delivery may describe bystander exposure better than vapers exposure.

[1]  C. Kleinstreuer,et al.  Size-change and deposition of conventional and composite cigarette smoke particles during inhalation in a subject-specific airway model , 2012 .

[2]  Walton Sumner,et al.  Interviews with "vapers": implications for future research with electronic cigarettes. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[3]  M. Trehy,et al.  Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. , 2010, Journal of chromatography. A.

[4]  P. Talbot,et al.  Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[5]  D. Dunn-Rankin,et al.  A transport model for nicotine in the tracheobronchial and pulmonary region of the lung , 2010, Inhalation toxicology.

[6]  N. Benowitz Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. , 2009, Annual review of pharmacology and toxicology.

[7]  K. Kurdziel,et al.  Condensational Growth May Contribute to the Enhanced Deposition of Cigarette Smoke Particles in the Upper Respiratory Tract , 2008 .

[8]  S. Jamnik,et al.  Localização do carcinoma pulmonar em relação ao vício tabágico e ao sexo , 2006 .

[9]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[10]  D. Broday,et al.  Application of Cloud Dynamics to Dosimetry of Cigarette Smoke Particles in the Lungs , 2003 .

[11]  M. Laugesen,et al.  Safety Report on the Ruyan ® e-cigarette Cartridge and Inhaled Aerosol , 2008 .

[12]  S. Jamnik,et al.  Location of lung carcinoma in relation to the smoking habit and gender. , 2006, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[13]  Mo Amin,et al.  Does a perception of increased blood safety mean increased blood transfusion? An assessment of the risk compensation theory in Canada , 2004, BMC public health.

[14]  Icrp Human Respiratory Tract Model for Radiological Protection , 1994 .

[15]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[16]  O. Parkash Lung cancer. A statistical study based on autopsy data from 1928 to 1972. , 1977, Respiration; international review of thoracic diseases.